CFA
ACER

Carroll Financial Associates’s Acer Therapeutics Inc ACER Stock Holding History

Carroll Financial Associates’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-120
Closed -$2K – 1549
2018
Q4 		$2K Buy
+120
New +$2.76K ﹤0.01% 1195

Other funds holding ACER

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Carroll Financial Associates's ACER Position: Q1 2019 in Review

Carroll Financial Associates sold out of Acer Therapeutics Inc (ACER) in Q1 2019, closing a stake of 120 shares — an estimated $2K sold.

Carroll Financial Associates first reported a position in ACER in Q4 2018 and held it in 1 quarter. The position peaked at $2K in Q4 2018. 34 funds tracked by Wall St. Rank hold ACER as of Q1 2019.

  • Carroll Financial Associates reported no remaining Acer Therapeutics Inc position as of Q1 2019 after selling out during the quarter.
  • Carroll Financial Associates sold 120 Acer Therapeutics Inc shares in Q1 2019, an estimated $2K.
  • Carroll Financial Associates first reported a position in Acer Therapeutics Inc in Q4 2018 and held it in 1 quarter.
  • Carroll Financial Associates's Acer Therapeutics Inc position peaked at $2K in Q4 2018.
  • 34 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q1 2019.

Based on Carroll Financial Associates's 13F filing for Q1 2019, filed 17 Apr 2019.